Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Yunho Jin, Da‐Young Eum, Chaeyoung Lee, Soon Yong Park, Jae Woong Shim, Yoo Jin Choi, Si Ho Choi, Joong‐Gook Kim, Kyu Heo, Seong‐Joon Park |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer
por: Dan Zhang, et al.
Publicado: (2026)
por: Dan Zhang, et al.
Publicado: (2026)
Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis
por: Priti S. Shenoy, et al.
Publicado: (2025)
por: Priti S. Shenoy, et al.
Publicado: (2025)
STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway
por: Junyi Jin, et al.
Publicado: (2024)
por: Junyi Jin, et al.
Publicado: (2024)
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
por: Banglun Pan, et al.
Publicado: (2024)
por: Banglun Pan, et al.
Publicado: (2024)
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
por: Xiaoyu Xiong, et al.
Publicado: (2024)
por: Xiaoyu Xiong, et al.
Publicado: (2024)
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
por: Junqi Wang, et al.
Publicado: (2024)
por: Junqi Wang, et al.
Publicado: (2024)
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
por: Anna Han, et al.
Publicado: (2024)
por: Anna Han, et al.
Publicado: (2024)
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
por: Keping Deng, et al.
Publicado: (2024)
por: Keping Deng, et al.
Publicado: (2024)
RhoGDIβ inhibition via miR‐200c/AUF1/SOX2/miR‐137 axis contributed to lncRNA MEG3 downregulation‐mediated malignant transformation of human bronchial epithelial cells
por: Yichao Yang, et al.
Publicado: (2024)
por: Yichao Yang, et al.
Publicado: (2024)
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
por: Yunyun Liu, et al.
Publicado: (2024)
por: Yunyun Liu, et al.
Publicado: (2024)
ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer
por: Dongsheng He, et al.
Publicado: (2024)
por: Dongsheng He, et al.
Publicado: (2024)
GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma
por: Zheng Yin, et al.
Publicado: (2024)
por: Zheng Yin, et al.
Publicado: (2024)
TSPAN31 Activates Fatty Acid Metabolism and PI3K/AKT Pathway to Promote Tumor Progression in Breast Cancer
por: Wenquan Luo, et al.
Publicado: (2025)
por: Wenquan Luo, et al.
Publicado: (2025)
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
por: Yecheng Li, et al.
Publicado: (2024)
por: Yecheng Li, et al.
Publicado: (2024)
Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway
por: Shangwei Xu, et al.
Publicado: (2025)
por: Shangwei Xu, et al.
Publicado: (2025)
Inhibition of Growth and Survival of Head and Neck Cancer Cells by Silibinin Involves the Down‐Regulation of Erk1/2, AKT and STAT3 Signaling
por: Navneendra Singh, et al.
Publicado: (2025)
por: Navneendra Singh, et al.
Publicado: (2025)
Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma
por: Yi Zhang, et al.
Publicado: (2024)
por: Yi Zhang, et al.
Publicado: (2024)
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia
por: Ru Zhang, et al.
Publicado: (2024)
por: Ru Zhang, et al.
Publicado: (2024)
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway
por: Xiaowen Ma, et al.
Publicado: (2024)
por: Xiaowen Ma, et al.
Publicado: (2024)
Combined treatment with Aronia berry extract and oligomeric proanthocyanidins exhibit a synergistic anticancer efficacy through LMNB1‐AKT signaling pathways in colorectal cancer
por: Yuan Li, et al.
Publicado: (2024)
por: Yuan Li, et al.
Publicado: (2024)
RETRACTION: LINC02381 Aggravates Breast Cancer Through the miR‐1271‐5p/FN1 Axis to Activate PI3K/AKT Pathway
Publicado: (2024)
Publicado: (2024)
LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K–AKT–mTOR Signaling Pathway by Interacting With IGF2BP2
por: Mingyuan Zhang, et al.
Publicado: (2025)
por: Mingyuan Zhang, et al.
Publicado: (2025)
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer
por: Qi Zhang, et al.
Publicado: (2024)
por: Qi Zhang, et al.
Publicado: (2024)
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells
por: Ni Lan, et al.
Publicado: (2024)
por: Ni Lan, et al.
Publicado: (2024)
Long Non‐Coding RNA PTPRG‐AS1 Promotes Proliferation, Migration, and Invasion of Non‐Small Cell Lung Cancer Cells via Modulation of the IGF1/PI3K/AKT Signaling Pathway
por: Gongzhang Su, et al.
Publicado: (2026)
por: Gongzhang Su, et al.
Publicado: (2026)
Precision therapy for cancer prevention by targeting carcinogenesis
por: Guoguo Jin, et al.
Publicado: (2024)
por: Guoguo Jin, et al.
Publicado: (2024)
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2
por: Qing Xia, et al.
Publicado: (2024)
por: Qing Xia, et al.
Publicado: (2024)
Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin
por: Yifan Zhang, et al.
Publicado: (2024)
por: Yifan Zhang, et al.
Publicado: (2024)
Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies
por: Ivan Lu, et al.
Publicado: (2026)
por: Ivan Lu, et al.
Publicado: (2026)
AN02, a Naovel Curcumin Derivative, Orchestrates APC‐SMAD4‐Mediated CTLA‐4 Degradation for Ovarian Cancer Therapy
por: Hairong Jin, et al.
Publicado: (2025)
por: Hairong Jin, et al.
Publicado: (2025)
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity
por: Kieun Bae, et al.
Publicado: (2024)
por: Kieun Bae, et al.
Publicado: (2024)
A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer
por: Xiaolu Hu, et al.
Publicado: (2026)
por: Xiaolu Hu, et al.
Publicado: (2026)
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma
por: Hongrui Zhou, et al.
Publicado: (2024)
por: Hongrui Zhou, et al.
Publicado: (2024)
Noncanonical Pathways of Proteasome Inhibition in HPV‐Negative Head & Neck Cancer
por: Hye‐Yeon Lee, et al.
Publicado: (2025)
por: Hye‐Yeon Lee, et al.
Publicado: (2025)
Cover Image, Volume 63, Issue 5
por: Mengqiu Song, et al.
Publicado: (2024)
por: Mengqiu Song, et al.
Publicado: (2024)
Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Mengqiu Song, et al.
Publicado: (2024)
por: Mengqiu Song, et al.
Publicado: (2024)
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway
por: Junfeng Li, et al.
Publicado: (2024)
por: Junfeng Li, et al.
Publicado: (2024)
C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer
por: Bo Liu, et al.
Publicado: (2024)
por: Bo Liu, et al.
Publicado: (2024)
High‐Fat Diet Promotes Glycolysis in Hepatocellular Carcinoma by Suppressing Hepatic Kisspeptin Signaling in Mice
por: Rongqian Zhao, et al.
Publicado: (2025)
por: Rongqian Zhao, et al.
Publicado: (2025)
Helicobacter pylori Infection, Metabolomic Signature and Extra‐gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis
por: Yan Chen, et al.
Publicado: (2025)
por: Yan Chen, et al.
Publicado: (2025)
Ejemplares similares
-
CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer
por: Dan Zhang, et al.
Publicado: (2026) -
Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis
por: Priti S. Shenoy, et al.
Publicado: (2025) -
STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway
por: Junyi Jin, et al.
Publicado: (2024) -
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
por: Banglun Pan, et al.
Publicado: (2024) -
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
por: Xiaoyu Xiong, et al.
Publicado: (2024)